{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T07:05:33Z","timestamp":1769324733349,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008061","name":"Mutua Madrile\u00f1a Foundation","doi-asserted-by":"publisher","award":["FMM21\/01"],"award-info":[{"award-number":["FMM21\/01"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["PEJD-2021-TL\/BMD-21113"],"award-info":[{"award-number":["PEJD-2021-TL\/BMD-21113"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014365","name":"Gregorio Maranon Health Research Institute","doi-asserted-by":"publisher","award":["2022-PI-II-COOPTR-01"],"award-info":[{"award-number":["2022-PI-II-COOPTR-01"]}],"id":[{"id":"10.13039\/501100014365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008433","name":"Consejer\u00eda de Educaci\u00f3n, Juventud y Deporte, Comunidad de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008433","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/00344"],"award-info":[{"award-number":["PI21\/00344"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["FI22\/00022"],"award-info":[{"award-number":["FI22\/00022"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["MSII18\/00008"],"award-info":[{"award-number":["MSII18\/00008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2025.e41885","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T20:43:07Z","timestamp":1736455387000},"page":"e41885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is an oritavancin catheter lock solution active against biofilms of staphylococci and enterococci?"],"prefix":"10.1016","volume":"11","author":[{"given":"Marta","family":"D\u00edaz-Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Visedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jes\u00fas","family":"P\u00e9rez-Granda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-5848","authenticated-orcid":false,"given":"Mar\u00eda","family":"Guembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2025.e41885_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2217\/fmb-2017-0310","article-title":"Oritavancin: an update","volume":"13","author":"Fl\u00fch","year":"2018","journal-title":"Future Microbiol."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e41885_bib2","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkz162","article-title":"On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections","volume":"74","author":"Morrisette","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41885_bib3","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1128\/AAC.00169-16","article-title":"Comparative in vitro activities of oritavancin, dalbavancin, and vancomycin against methicillin-resistant Staphylococcus aureus isolates in a nondividing state","volume":"60","author":"Belley","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41885_bib4","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/jac\/dkw319","article-title":"Longitudinal (2001-14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010-13) analysis of oritavancin in vitro potency","volume":"71","author":"Mendes","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/dkw451","article-title":"Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci","volume":"72","author":"Sweeney","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41885_bib6","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/AAC.00760-10","article-title":"Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing","volume":"54","author":"Belley","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41885_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106069","article-title":"Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: a systematic review","volume":"56","author":"Thomas","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.heliyon.2025.e41885_bib8","article-title":"New perspectives on antimicrobial agents: long-acting lipoglycopeptides","volume":"66","author":"Tran","year":"2022"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41885_bib9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3390\/life13040959","article-title":"Role of oritavancin in the treatment of infective endocarditis, catheter- or device-related infections, bloodstream infections, and bone and prosthetic joint infections in humans: narrative review and possible developments","volume":"13","author":"Lupia","year":"2023","journal-title":"Life"},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41885_bib10","first-page":"143","article-title":"Oritavancin (orbactiv): a new-generation lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections","volume":"43","author":"Rosenthal","year":"2018","journal-title":"P & T: Peer-Reviewed J. Formul. Manag."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41885_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41885_bib12","first-page":"54","article-title":"Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters","volume":"21","author":"Beigi","year":"2010","journal-title":"Saudi J. Kidney Dis. Transplant."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.diagmicrobio.2008.10.004","article-title":"Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections","volume":"63","author":"Del Pozo","year":"2009","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41885_bib14","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1128\/AAC.01855-15","article-title":"Tigecycline lock therapy for catheter-related bloodstream infection caused by KPC-producing Klebsiella pneumoniae in two pediatric hematological patients","volume":"59","author":"Foresti","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41885_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkl318","article-title":"Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy","volume":"58","author":"Fort\u00fan","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.heliyon.2025.e41885_bib16","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1093\/cid\/cir551","article-title":"Effectiveness of antibiotic-lock therapy for long-term catheter-related bacteremia due to Gram-negative bacilli: a prospective observational study","volume":"53","author":"Funalleras","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41885_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/ajcn\/nqab164","article-title":"Comparing success rates in central venous catheter salvage for catheter-related bloodstream infections in adult patients on home parenteral nutrition: a systematic review and meta-analysis","volume":"114","author":"Gompelman","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41885_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1086\/502157","article-title":"Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia","volume":"24","author":"Kim","year":"2003","journal-title":"Infect. Control Hosp. Epidemiol."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41885_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1046\/j.1523-1755.2002.00201.x","article-title":"Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution","volume":"61","author":"Krishnasami","year":"2002","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.heliyon.2025.e41885_bib20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00277-010-1004-3","article-title":"Outcome of attempted Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia","volume":"89","author":"Park","year":"2010","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41885_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s15010-014-0675-4","article-title":"Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter","volume":"43","author":"Tatarelli","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41885_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.ajkd.2008.06.033","article-title":"Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report","volume":"53","author":"Peterson","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/hdi.12378","article-title":"Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis","volume":"20","author":"Yen","year":"2016","journal-title":"Hemodialysis Int. Symp. Home Hemodialysis"},{"issue":"3","key":"10.1016\/j.heliyon.2025.e41885_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1129729819875323","article-title":"High success rate in salvage of catheter-related bloodstream infections due to Staphylococcus aureus, on behalf of project group of Italian society of nephrology","volume":"21","author":"Mandolfo","year":"2020","journal-title":"J. Vasc. Access"},{"issue":"5","key":"10.1016\/j.heliyon.2025.e41885_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jac\/47.5.705","article-title":"Effect of LY333328 against vancomycin-resistant Enterococcus faecium in a rat central venous catheter-associated infection model","volume":"47","author":"Rupp","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e41885_bib26","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/AAC.43.8.2074","article-title":"Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports)","volume":"43","author":"Anthony","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"24","key":"10.1016\/j.heliyon.2025.e41885_bib27","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2146\/ajhp120119","article-title":"Stability and compatibility of antimicrobial lock solutions","volume":"70","author":"Bookstaver","year":"2013","journal-title":"Am. J. Health Syst. Pharm.: AJHP"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib28","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eimc.2008.09.016","article-title":"[Stability: a factor to consider in antibiotic-lock solutions]","volume":"28","author":"Morales-Molina","year":"2010","journal-title":"Enferm. Infecc. Microbiol. Cl\u00edn."},{"key":"10.1016\/j.heliyon.2025.e41885_bib29","series-title":"Enfermedades Infecciosas Y Microbiologia Clinica","article-title":"Reporting antimicrobial susceptibilities and phenotypes of resistance to vancomycin in vancomycin-resistant Enterococcus spp. clinical isolates: a nationwide proficiency study","author":"Fern\u00e1ndez-Cuenca","year":"2021"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mimet.2007.11.010","article-title":"Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates","volume":"72","author":"Peeters","year":"2008","journal-title":"J. Microbiol. Methods"},{"issue":"10","key":"10.1016\/j.heliyon.2025.e41885_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00943-18","article-title":"Evaluation of oritavancin combinations with rifampin, gentamicin, or linezolid against prosthetic joint infection-associated methicillin-resistant Staphylococcus aureus biofilms by time-kill assays","volume":"62","author":"Yan","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e41885_bib32","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.03006-15","article-title":"Oritavancin combinations with \u03b2-lactams against multidrug-resistant Staphylococcus aureus and vancomycin-resistant enterococci","volume":"60","author":"Smith","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e41885_bib33","article-title":"In vitro and in vivo studies of oritavancin and fosfomycin synergism against vancomycin-resistant Enterococcus faecium","volume":"11","author":"Lagatolla","year":"2022"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e41885_bib34","first-page":"31","article-title":"Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment","volume":"36","author":"Di Cecco","year":"2024"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e41885_bib35","first-page":"743","article-title":"A dalbavancin lock solution can reduce enterococcal biofilms after freezing","volume":"11","author":"D\u00edaz-Navarro","year":"2022"},{"issue":"7","key":"10.1016\/j.heliyon.2025.e41885_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1099\/jmm.0.000749","article-title":"Can dalbavancin be used as a catheter lock solution?","volume":"67","author":"D\u00edaz-Ru\u00edz","year":"2018","journal-title":"J. Med. Microbiol."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e41885_bib37","article-title":"In vitro study to evaluate the bioactivity of freezing a heparin-based dalbavancin lock solution","volume":"64","author":"Rubia","year":"2020","journal-title":"Infect. Dis. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025002658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025002658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:28:29Z","timestamp":1769034509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025002658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844025002658"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41885","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is an oritavancin catheter lock solution active against biofilms of staphylococci and enterococci?","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e41885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41885"}}